Evotec Research Development from 2010 to 2026

EVO Stock  USD 3.65  0.13  3.44%   
Evotec SE Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 38.4 M. During the period from 2010 to 2026, Evotec SE Research Development quarterly data regression pattern had sample variance of 907.1 T and median of  35,619,000. View All Fundamentals
 
Research Development  
First Reported
2003-09-30
Previous Quarter
8.2 M
Current Value
8.7 M
Quarterly Volatility
5.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Evotec SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evotec SE's main balance sheet or income statement drivers, such as Other Operating Expenses of 1.1 B, Total Operating Expenses of 310.8 M or Income Tax Expense of 2 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0011 or PTB Ratio of 2.12. Evotec financial statements analysis is a perfect complement when working with Evotec SE Valuation or Volatility modules.
  
Build AI portfolio with Evotec Stock
Check out the analysis of Evotec SE Correlation against competitors.
Evaluating Evotec SE's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Evotec SE ADR's fundamental strength.

Latest Evotec SE's Research Development Growth Pattern

Below is the plot of the Research Development of Evotec SE ADR over the last few years. It is Evotec SE's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evotec SE's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Evotec Research Development Regression Statistics

Arithmetic Mean38,735,234
Geometric Mean27,867,837
Coefficient Of Variation77.75
Mean Deviation24,835,872
Median35,619,000
Standard Deviation30,118,359
Sample Variance907.1T
Range104.2M
R-Value0.77
Mean Square Error392.8T
R-Squared0.59
Significance0.0003
Slope4,596,777
Total Sum of Squares14513.8T

Evotec Research Development History

202638.4 M
202558.5 M
202450.9 M
2023112.5 M
202276.6 M
202165.7 M
202059.6 M

About Evotec SE Financial Statements

Evotec SE investors utilize fundamental indicators, such as Research Development, to predict how Evotec Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development58.5 M38.4 M

Pair Trading with Evotec SE

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.

Moving together with Evotec Stock

  0.62XBIO Xenetic BiosciencesPairCorr

Moving against Evotec Stock

  0.62ZBIO Zenas BioPharma CommonPairCorr
  0.49ZYME Zymeworks Common StockPairCorr
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE ADR to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:
Check out the analysis of Evotec SE Correlation against competitors.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Will Biotechnology sector continue expanding? Could Evotec diversify its offerings? Factors like these will boost the valuation of Evotec SE. Projected growth potential of Evotec fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Evotec SE data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.54)
Revenue Per Share
2.13
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.03)
Return On Equity
(0.18)
Understanding Evotec SE ADR requires distinguishing between market price and book value, where the latter reflects Evotec's accounting equity. The concept of intrinsic value—what Evotec SE's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Evotec SE's price substantially above or below its fundamental value.
It's important to distinguish between Evotec SE's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evotec SE should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evotec SE's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.